2021年欧洲《阿片类药物治疗慢性非癌性疼痛的临床实践建议》解读  

Interpretation of European Clinical Practice Recommendations on Opioids for Chronic Non-cancer Pain 2021

作　　者：易小清 崔小娇 陈祝君 边原[1] 陈岷[1] YI Xiaoqing;CUI Xiaojiao;CHEN Zhujun;BIAN Yuan;CHEN Min(Department of Pharmacy & Personalized Drug Therapy Key Laboratory of Sichuan Province,Sichuan Provincial People’s Hospital /Affiliated Hospital of University of Electronic Science and Technology of China,Sichuan Academy of Medical Sciences,Chengdu 610072,China)

机构地区：[1]四川省医学科学院·四川省人民医院/电子科技大学附属医院药学部·个体化药物治疗四川省重点实验室,成都610072

出　　处：《医药导报》2021年第9期1176-1182,共7页Herald of Medicine

摘　　要：阿片类药物镇痛效果强,不易引起重要脏器损伤,是特殊管理的麻醉精神药品。慢性非癌性疼痛的治疗是一个长期、持续的过程,阿片类药物在治疗慢性非癌性疼痛方面越来越受到重视。2021年3月,欧洲疼痛联盟发布了《阿片类药物治疗慢性非癌性疼痛的临床实践建议》,该文对此进行解读,主要内容涉及阿片类药物在慢性非癌性疼痛治疗中的作用、临床实践及特殊情况下的使用,以期加深医务工作者对指南的认识,促进阿片类药物在慢性非癌性疼痛治疗中的规范化应用。Opioids are potent analgesics,and they are not easy to cause injury to important organs.However,they are specially managed anesthetics.The treatment of chronic non-cancer pain(CNCP)is a long-term and continuous process.Opioids have been paid more and more attention in the treatment of chronic non-cancer pain.In March 2021,the European Pain Federation(EFIC)issued the clinical practice recommendations on opioids for chronic non-cancer pain.Therefore,in order to deepen medical staff’s understanding of the guidelines and promote the standardized treatment of opioids in chronic non-cancer pain,this paper interprets the practice recommendations,including the role of opioids in the treatment of chronic non-cancer pain,clinical practice,and the use of opioids in special cases.

关 键 词：阿片类药物 疼痛 非癌性 慢性 解读 

分 类 号：R971.2[医药卫生—药品] R969.3[医药卫生—药学]